APO Research
Talk to an analyst

APO RESEARCH · REPORT

Analgesic and Anti-inflammatory API

Compare research editions
View pricing & licenses

Selected research

Industry Research

Analgesic and Anti-inflammatory API Industry Research Report 2026

1 February 2026126 pages

Choose your research edition.

Industry ResearchAnalgesic and Anti-inflammatory API Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Analgesic and Anti-inflammatory API Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Analgesic and Anti-inflammatory API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Analgesic and Anti-inflammatory API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Analgesic and Anti-inflammatory API Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Analgesic and Anti-inflammatory API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Analgesic and Anti-inflammatory API is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Analgesic and Anti-inflammatory API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Analgesic and Anti-inflammatory API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Analgesic and Anti-inflammatory API include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Analgesic and Anti-inflammatory API market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Analgesic and Anti-inflammatory API.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Analgesic and Anti-inflammatory API Market by Company

IOL

Granules India Limited

Mallinckrodt Pharmaceuticals

Novacyl

BASF

Hubei Biocause Group

BBCA Group

Hebei Jiheng Pharmaceutical

Hunan Zhongnan Pharmaceutical

Hebei Jingye Medical Technology

Anqiu Lu'an Pharmaceutical

Xinhua Pharm

Zhejiang Kangle Pharmaceutical

Analgesic and Anti-inflammatory API Segment by Type

Dexibuprofen

Diclofenac

Paracetamol

Naproxen

Ibuprofen

Oxaprozin

Aspirin

Others

Analgesic and Anti-inflammatory API Segment by Application

Adults

Children

Analgesic and Anti-inflammatory API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Analgesic and Anti-inflammatory API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Analgesic and Anti-inflammatory API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Analgesic and Anti-inflammatory API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Analgesic and Anti-inflammatory API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Analgesic and Anti-inflammatory API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Analgesic and Anti-inflammatory API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Analgesic and Anti-inflammatory API Production by Manufacturers (t) & (2021-2026) Table 6. Global Analgesic and Anti-inflammatory API Production Market Share by Manufacturers Table 7. Global Analgesic and Anti-inflammatory API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Analgesic and Anti-inflammatory API Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Analgesic and Anti-inflammatory API Average Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Analgesic and Anti-inflammatory API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Analgesic and Anti-inflammatory API Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Analgesic and Anti-inflammatory API Manufacturers, Product Type & Application Table 13. Global Analgesic and Anti-inflammatory API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Analgesic and Anti-inflammatory API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. IOL Company Information Table 18. IOL Business Overview Table 19. IOL Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 20. IOL Analgesic and Anti-inflammatory API Product Portfolio Table 21. IOL Recent Development Table 22. Granules India Limited Company Information Table 23. Granules India Limited Business Overview Table 24. Granules India Limited Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 25. Granules India Limited Analgesic and Anti-inflammatory API Product Portfolio Table 26. Granules India Limited Recent Development Table 27. Mallinckrodt Pharmaceuticals Company Information Table 28. Mallinckrodt Pharmaceuticals Business Overview Table 29. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 30. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolio Table 31. Mallinckrodt Pharmaceuticals Recent Development Table 32. Novacyl Company Information Table 33. Novacyl Business Overview Table 34. Novacyl Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 35. Novacyl Analgesic and Anti-inflammatory API Product Portfolio Table 36. Novacyl Recent Development Table 37. BASF Company Information Table 38. BASF Business Overview Table 39. BASF Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 40. BASF Analgesic and Anti-inflammatory API Product Portfolio Table 41. BASF Recent Development Table 42. Hubei Biocause Group Company Information Table 43. Hubei Biocause Group Business Overview Table 44. Hubei Biocause Group Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolio Table 46. Hubei Biocause Group Recent Development Table 47. BBCA Group Company Information Table 48. BBCA Group Business Overview Table 49. BBCA Group Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 50. BBCA Group Analgesic and Anti-inflammatory API Product Portfolio Table 51. BBCA Group Recent Development Table 52. Hebei Jiheng Pharmaceutical Company Information Table 53. Hebei Jiheng Pharmaceutical Business Overview Table 54. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 55. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 56. Hebei Jiheng Pharmaceutical Recent Development Table 57. Hunan Zhongnan Pharmaceutical Company Information Table 58. Hunan Zhongnan Pharmaceutical Business Overview Table 59. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 60. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 61. Hunan Zhongnan Pharmaceutical Recent Development Table 62. Hebei Jingye Medical Technology Company Information Table 63. Hebei Jingye Medical Technology Business Overview Table 64. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 65. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolio Table 66. Hebei Jingye Medical Technology Recent Development Table 67. Anqiu Lu'an Pharmaceutical Company Information Table 68. Anqiu Lu'an Pharmaceutical Business Overview Table 69. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 71. Anqiu Lu'an Pharmaceutical Recent Development Table 72. Xinhua Pharm Company Information Table 73. Xinhua Pharm Business Overview Table 74. Xinhua Pharm Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolio Table 76. Xinhua Pharm Recent Development Table 77. Zhejiang Kangle Pharmaceutical Company Information Table 78. Zhejiang Kangle Pharmaceutical Business Overview Table 79. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 81. Zhejiang Kangle Pharmaceutical Recent Development Table 82. Global Analgesic and Anti-inflammatory API Production Comparison by Region: 2021 VS 2025 VS 2032 (t) Table 83. Global Analgesic and Anti-inflammatory API Production by Region (2021-2026) & (t) Table 84. Global Analgesic and Anti-inflammatory API Production Market Share by Region (2021-2026) Table 85. Global Analgesic and Anti-inflammatory API Production Forecast by Region (2027-2032) & (t) Table 86. Global Analgesic and Anti-inflammatory API Production Market Share Forecast by Region (2027-2032) Table 87. Global Analgesic and Anti-inflammatory API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Global Analgesic and Anti-inflammatory API Production Value by Region (2021-2026) & (US$ Million) Table 89. Global Analgesic and Anti-inflammatory API Production Value Market Share by Region (2021-2026) Table 90. Global Analgesic and Anti-inflammatory API Production Value Forecast by Region (2027-2032) & (US$ Million) Table 91. Global Analgesic and Anti-inflammatory API Market Average Price (USD/t) by Region (2021-2026) Table 92. Global Analgesic and Anti-inflammatory API Market Average Price (USD/t) by Region (2027-2032) Table 93. Global Analgesic and Anti-inflammatory API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (t) Table 94. Global Analgesic and Anti-inflammatory API Consumption by Region (2021-2026) & (t) Table 95. Global Analgesic and Anti-inflammatory API Consumption Market Share by Region (2021-2026) Table 96. Global Analgesic and Anti-inflammatory API Forecasted Consumption by Region (2027-2032) & (t) Table 97. Global Analgesic and Anti-inflammatory API Forecasted Consumption Market Share by Region (2027-2032) Table 98. North America Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 99. North America Analgesic and Anti-inflammatory API Consumption by Country (2021-2026) & (t) Table 100. North America Analgesic and Anti-inflammatory API Consumption by Country (2027-2032) & (t) Table 101. Europe Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 102. Europe Analgesic and Anti-inflammatory API Consumption by Country (2021-2026) & (t) Table 103. Europe Analgesic and Anti-inflammatory API Consumption by Country (2027-2032) & (t) Table 104. Asia Pacific Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 105. Asia Pacific Analgesic and Anti-inflammatory API Consumption by Country (2021-2026) & (t) Table 106. Asia Pacific Analgesic and Anti-inflammatory API Consumption by Country (2027-2032) & (t) Table 107. South America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 108. South America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption by Country (2021-2026) & (t) Table 109. South America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption by Country (2027-2032) & (t) Table 110. Global Analgesic and Anti-inflammatory API Production by Type (2021-2026) & (t) Table 111. Global Analgesic and Anti-inflammatory API Production by Type (2027-2032) & (t) Table 112. Global Analgesic and Anti-inflammatory API Production Market Share by Type (2021-2026) Table 113. Global Analgesic and Anti-inflammatory API Production Market Share by Type (2027-2032) Table 114. Global Analgesic and Anti-inflammatory API Production Value by Type (2021-2026) & (US$ Million) Table 115. Global Analgesic and Anti-inflammatory API Production Value by Type (2027-2032) & (US$ Million) Table 116. Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2021-2026) Table 117. Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2027-2032) Table 118. Global Analgesic and Anti-inflammatory API Price by Type (2021-2026) & (USD/t) Table 119. Global Analgesic and Anti-inflammatory API Price by Type (2027-2032) & (USD/t) Table 120. Global Analgesic and Anti-inflammatory API Production by Application (2021-2026) & (t) Table 121. Global Analgesic and Anti-inflammatory API Production by Application (2027-2032) & (t) Table 122. Global Analgesic and Anti-inflammatory API Production Market Share by Application (2021-2026) Table 123. Global Analgesic and Anti-inflammatory API Production Market Share by Application (2027-2032) Table 124. Global Analgesic and Anti-inflammatory API Production Value by Application (2021-2026) & (US$ Million) Table 125. Global Analgesic and Anti-inflammatory API Production Value by Application (2027-2032) & (US$ Million) Table 126. Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2021-2026) Table 127. Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2027-2032) Table 128. Global Analgesic and Anti-inflammatory API Price by Application (2021-2026) & (USD/t) Table 129. Global Analgesic and Anti-inflammatory API Price by Application (2027-2032) & (USD/t) Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Analgesic and Anti-inflammatory API Distributors List Table 133. Analgesic and Anti-inflammatory API Customers List Table 134. Analgesic and Anti-inflammatory API Industry Trends Table 135. Analgesic and Anti-inflammatory API Industry Drivers Table 136. Analgesic and Anti-inflammatory API Industry Restraints Table 137. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Analgesic and Anti-inflammatory API Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Dexibuprofen Product Image Figure 7. Diclofenac Product Image Figure 8. Paracetamol Product Image Figure 9. Naproxen Product Image Figure 10. Ibuprofen Product Image Figure 11. Oxaprozin Product Image Figure 12. Aspirin Product Image Figure 13. Others Product Image Figure 14. Adults Product Image Figure 15. Children Product Image Figure 16. Global Analgesic and Anti-inflammatory API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Analgesic and Anti-inflammatory API Production Value (2021-2032) & (US$ Million) Figure 18. Global Analgesic and Anti-inflammatory API Production Capacity (2021-2032) & (t) Figure 19. Global Analgesic and Anti-inflammatory API Production (2021-2032) & (t) Figure 20. Global Analgesic and Anti-inflammatory API Average Price (USD/t) & (2021-2032) Figure 21. Global Analgesic and Anti-inflammatory API Key Manufacturers, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Analgesic and Anti-inflammatory API Players Market Share by Production Value in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Analgesic and Anti-inflammatory API Production Comparison by Region: 2021 VS 2025 VS 2032 (t) Figure 25. Global Analgesic and Anti-inflammatory API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 26. Global Analgesic and Anti-inflammatory API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 27. Global Analgesic and Anti-inflammatory API Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. North America Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021-2032) Figure 29. Europe Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021-2032) Figure 30. China Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021-2032) Figure 31. Japan Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021-2032) Figure 32. Global Analgesic and Anti-inflammatory API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (t) Figure 33. Global Analgesic and Anti-inflammatory API Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 35. North America Analgesic and Anti-inflammatory API Consumption Market Share by Country (2021-2032) Figure 36. United States Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 37. United States Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 38. Canada Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 39. Mexico Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 40. Europe Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 41. Europe Analgesic and Anti-inflammatory API Consumption Market Share by Country (2021-2032) Figure 42. Germany Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 43. France Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 44. U.K. Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 45. Italy Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 46. Russia Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 47. Spain Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 48. Netherlands Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 49. Switzerland Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 50. Sweden Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 51. Poland Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 52. Asia Pacific Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 53. Asia Pacific Analgesic and Anti-inflammatory API Consumption Market Share by Country (2021-2032) Figure 54. China Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 55. Japan Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 56. South Korea Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 57. India Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 58. Australia Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 59. Taiwan Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 60. Southeast Asia Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 61. South America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 62. South America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption Market Share by Country (2021-2032) Figure 63. Brazil Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 64. Argentina Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 65. Chile Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 66. Turkey Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 67. GCC Countries Analgesic and Anti-inflammatory API Consumption and Growth Rate (2021-2032) & (t) Figure 68. Global Analgesic and Anti-inflammatory API Production Market Share by Type (2021-2032) Figure 69. Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2021-2032) Figure 70. Global Analgesic and Anti-inflammatory API Price (USD/t) by Type (2021-2032) Figure 71. Global Analgesic and Anti-inflammatory API Production Market Share by Application (2021-2032) Figure 72. Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2021-2032) Figure 73. Global Analgesic and Anti-inflammatory API Price (USD/t) by Application (2021-2032) Figure 74. Analgesic and Anti-inflammatory API Value Chain Figure 75. Analgesic and Anti-inflammatory API Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Analgesic and Anti-inflammatory API Industry Opportunities and Challenges

Scope & coverage.

Types
  • Dexibuprofen
  • Diclofenac
  • Paracetamol
  • Naproxen
  • Ibuprofen
  • Oxaprozin
  • Aspirin
  • Others
Applications
  • Adults
  • Children
Companies covered
  • IOL
  • Granules India Limited
  • Mallinckrodt Pharmaceuticals
  • Novacyl
  • BASF
  • Hubei Biocause Group
  • BBCA Group
  • Hebei Jiheng Pharmaceutical
  • Hunan Zhongnan Pharmaceutical
  • Hebei Jingye Medical Technology
  • Anqiu Lu'an Pharmaceutical
  • Xinhua Pharm
  • Zhejiang Kangle Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Analgesic and Anti-inflammatory API by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Dexibuprofen
  5. 2.2.3 Diclofenac
  6. 2.2.4 Paracetamol
  7. 2.2.5 Naproxen
  8. 2.2.6 Ibuprofen
  9. 2.2.7 Oxaprozin
  10. 2.2.8 Aspirin
  11. 2.2.9 Others
  12. 2.3 Analgesic and Anti-inflammatory API by Application
  13. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  14. 2.3.2 Adults
  15. 2.3.3 Children
  16. 2.4 Global Market Growth Prospects
  17. 2.4.1 Global Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021-2032)
  18. 2.4.2 Global Analgesic and Anti-inflammatory API Production Capacity Estimates and Forecasts (2021-2032)
  19. 2.4.3 Global Analgesic and Anti-inflammatory API Production Estimates and Forecasts (2021-2032)
  20. 2.4.4 Global Analgesic and Anti-inflammatory API Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Analgesic and Anti-inflammatory API Production by Manufacturers (2021-2026)
  2. 3.2 Global Analgesic and Anti-inflammatory API Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Analgesic and Anti-inflammatory API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Analgesic and Anti-inflammatory API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Analgesic and Anti-inflammatory API Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Analgesic and Anti-inflammatory API Manufacturers, Product Type & Application
  7. 3.7 Global Analgesic and Anti-inflammatory API Manufacturers Established Date
  8. 3.8 Global Analgesic and Anti-inflammatory API Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 IOL
  2. 4.1.1 IOL Analgesic and Anti-inflammatory API Company Information
  3. 4.1.2 IOL Analgesic and Anti-inflammatory API Business Overview
  4. 4.1.3 IOL Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 IOL Product Portfolio
  6. 4.1.5 IOL Recent Developments
  7. 4.2 Granules India Limited
  8. 4.2.1 Granules India Limited Analgesic and Anti-inflammatory API Company Information
  9. 4.2.2 Granules India Limited Analgesic and Anti-inflammatory API Business Overview
  10. 4.2.3 Granules India Limited Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Granules India Limited Product Portfolio
  12. 4.2.5 Granules India Limited Recent Developments
  13. 4.3 Mallinckrodt Pharmaceuticals
  14. 4.3.1 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Company Information
  15. 4.3.2 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Business Overview
  16. 4.3.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Mallinckrodt Pharmaceuticals Product Portfolio
  18. 4.3.5 Mallinckrodt Pharmaceuticals Recent Developments
  19. 4.4 Novacyl
  20. 4.4.1 Novacyl Analgesic and Anti-inflammatory API Company Information
  21. 4.4.2 Novacyl Analgesic and Anti-inflammatory API Business Overview
  22. 4.4.3 Novacyl Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Novacyl Product Portfolio
  24. 4.4.5 Novacyl Recent Developments
  25. 4.5 BASF
  26. 4.5.1 BASF Analgesic and Anti-inflammatory API Company Information
  27. 4.5.2 BASF Analgesic and Anti-inflammatory API Business Overview
  28. 4.5.3 BASF Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 BASF Product Portfolio
  30. 4.5.5 BASF Recent Developments
  31. 4.6 Hubei Biocause Group
  32. 4.6.1 Hubei Biocause Group Analgesic and Anti-inflammatory API Company Information
  33. 4.6.2 Hubei Biocause Group Analgesic and Anti-inflammatory API Business Overview
  34. 4.6.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Hubei Biocause Group Product Portfolio
  36. 4.6.5 Hubei Biocause Group Recent Developments
  37. 4.7 BBCA Group
  38. 4.7.1 BBCA Group Analgesic and Anti-inflammatory API Company Information
  39. 4.7.2 BBCA Group Analgesic and Anti-inflammatory API Business Overview
  40. 4.7.3 BBCA Group Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 BBCA Group Product Portfolio
  42. 4.7.5 BBCA Group Recent Developments
  43. 4.8 Hebei Jiheng Pharmaceutical
  44. 4.8.1 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Company Information
  45. 4.8.2 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Business Overview
  46. 4.8.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Hebei Jiheng Pharmaceutical Product Portfolio
  48. 4.8.5 Hebei Jiheng Pharmaceutical Recent Developments
  49. 4.9 Hunan Zhongnan Pharmaceutical
  50. 4.9.1 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Company Information
  51. 4.9.2 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Business Overview
  52. 4.9.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Hunan Zhongnan Pharmaceutical Product Portfolio
  54. 4.9.5 Hunan Zhongnan Pharmaceutical Recent Developments
  55. 4.10 Hebei Jingye Medical Technology
  56. 4.10.1 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Company Information
  57. 4.10.2 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Business Overview
  58. 4.10.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Hebei Jingye Medical Technology Product Portfolio
  60. 4.10.5 Hebei Jingye Medical Technology Recent Developments
  61. 4.11 Anqiu Lu'an Pharmaceutical
  62. 4.11.1 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Company Information
  63. 4.11.2 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Business Overview
  64. 4.11.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Anqiu Lu'an Pharmaceutical Product Portfolio
  66. 4.11.5 Anqiu Lu'an Pharmaceutical Recent Developments
  67. 4.12 Xinhua Pharm
  68. 4.12.1 Xinhua Pharm Analgesic and Anti-inflammatory API Company Information
  69. 4.12.2 Xinhua Pharm Analgesic and Anti-inflammatory API Business Overview
  70. 4.12.3 Xinhua Pharm Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Xinhua Pharm Product Portfolio
  72. 4.12.5 Xinhua Pharm Recent Developments
  73. 4.13 Zhejiang Kangle Pharmaceutical
  74. 4.13.1 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Company Information
  75. 4.13.2 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Business Overview
  76. 4.13.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 Zhejiang Kangle Pharmaceutical Product Portfolio
  78. 4.13.5 Zhejiang Kangle Pharmaceutical Recent Developments
5 Global Analgesic and Anti-inflammatory API Production by Region
  1. 5.1 Global Analgesic and Anti-inflammatory API Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Analgesic and Anti-inflammatory API Production by Region: 2021-2032
  3. 5.2.1 Global Analgesic and Anti-inflammatory API Production by Region: 2021-2026
  4. 5.2.2 Global Analgesic and Anti-inflammatory API Production Forecast by Region (2027-2032)
  5. 5.3 Global Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Analgesic and Anti-inflammatory API Production Value by Region: 2021-2032
  7. 5.4.1 Global Analgesic and Anti-inflammatory API Production Value by Region: 2021-2026
  8. 5.4.2 Global Analgesic and Anti-inflammatory API Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Analgesic and Anti-inflammatory API Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Analgesic and Anti-inflammatory API Production and Value, YOY Growth
  11. 5.6.1 North America Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021-2032)
6 Global Analgesic and Anti-inflammatory API Consumption by Region
  1. 6.1 Global Analgesic and Anti-inflammatory API Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Analgesic and Anti-inflammatory API Consumption by Region (2021-2032)
  3. 6.2.1 Global Analgesic and Anti-inflammatory API Consumption by Region: 2021-2026
  4. 6.2.2 Global Analgesic and Anti-inflammatory API Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Analgesic and Anti-inflammatory API Production by Type (2021-2032)
  2. 7.1.1 Global Analgesic and Anti-inflammatory API Production by Type (2021-2032) & (t)
  3. 7.1.2 Global Analgesic and Anti-inflammatory API Production Market Share by Type (2021-2032)
  4. 7.2 Global Analgesic and Anti-inflammatory API Production Value by Type (2021-2032)
  5. 7.2.1 Global Analgesic and Anti-inflammatory API Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Analgesic and Anti-inflammatory API Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Analgesic and Anti-inflammatory API Production by Application (2021-2032)
  2. 8.1.1 Global Analgesic and Anti-inflammatory API Production by Application (2021-2032) & (t)
  3. 8.1.2 Global Analgesic and Anti-inflammatory API Production Market Share by Application (2021-2032)
  4. 8.2 Global Analgesic and Anti-inflammatory API Production Value by Application (2021-2032)
  5. 8.2.1 Global Analgesic and Anti-inflammatory API Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Analgesic and Anti-inflammatory API Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Analgesic and Anti-inflammatory API Value Chain Analysis
  2. 9.1.1 Analgesic and Anti-inflammatory API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Analgesic and Anti-inflammatory API Production Mode & Process
  5. 9.2 Analgesic and Anti-inflammatory API Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Analgesic and Anti-inflammatory API Distributors
  8. 9.2.3 Analgesic and Anti-inflammatory API Customers
10 Global Analgesic and Anti-inflammatory API Analyzing Market Dynamics
  1. 10.1 Analgesic and Anti-inflammatory API Industry Trends
  2. 10.2 Analgesic and Anti-inflammatory API Industry Drivers
  3. 10.3 Analgesic and Anti-inflammatory API Industry Opportunities and Challenges
  4. 10.4 Analgesic and Anti-inflammatory API Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst